210 results on '"Fernandez-Cuesta, Lynnette"'
Search Results
2. Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity
3. Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers
4. Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force.
5. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors.
6. Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas
7. Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center
8. EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach
9. Variability of mutational signatures is a footprint of carcinogens
10. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
11. Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms
12. Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery
13. Exploring the interplay of RNA methylation and alternative splicing machineries in lung carcinoids
14. Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms
15. Data from CD74–NRG1 Fusions in Lung Adenocarcinoma
16. Data from Cell-Autonomous and Non–Cell-Autonomous Mechanisms of Transformation by Amplified FGFR1 in Lung Cancer
17. Supplementary Tables from CD74–NRG1 Fusions in Lung Adenocarcinoma
18. Supplementary Methods and Legends from Cell-Autonomous and Non–Cell-Autonomous Mechanisms of Transformation by Amplified FGFR1 in Lung Cancer
19. Supplementary Figures S1-S14 from Cell-Autonomous and Non–Cell-Autonomous Mechanisms of Transformation by Amplified FGFR1 in Lung Cancer
20. Supplementary Figures from CD74–NRG1 Fusions in Lung Adenocarcinoma
21. BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas
22. Supplementary Figure 3 from Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors
23. Figure S1 from Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome
24. Supplementary Figure 2 from Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors
25. Supplementary Data from Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors
26. Table S1 from Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome
27. Supplementary data file from Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome
28. Supplemental legend from Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome
29. Supplementary Figure 4 from Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors
30. HaloAE: A Local Transformer Auto-Encoder for Anomaly Detection and Localization Based on HaloNet
31. Small-Cell Cancer of the Lung: Pathology and Genetics
32. A molecular phenotypic map of malignant pleural mesothelioma
33. A molecular phenotypic map of Malignant Pleural Mesothelioma
34. Abstract 3744: Differential Orthopedia Homeobox (OTP) expression in pulmonary carcinoids is associated with changes in DNA methylation
35. A molecular phenotypic map of malignant pleural mesothelioma.
36. Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
37. Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation
38. Disentangling heterogeneity of Malignant Pleural Mesothelioma through deep integrative omics analyses
39. Altered splicing machinery as a source of biomarkers in lung neuroendocrine neoplasms
40. A molecular map of lung neuroendocrine neoplasms
41. New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts
42. p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines
43. Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data
44. Molecular studies of lung neuroendocrine neoplasms uncover new concepts and entities
45. Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions
46. Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data
47. Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypes
48. Multi-omics comparative analyses of pulmonary typical carcinoids, atypical carcinoids, and large-cell neuroendocrine carcinoma
49. A Case-Control Study to Test the Use of ctDNA in the Early Detection of SCLC Reveals TP53 Mutations in Non-Cancer Controls
50. Abstract 5358: Multi-omics comparative analyses of pulmonary typical carcinoids, atypical carcinoids, and large-cell neuroendocrine carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.